As stated earlier, Dr. Tervaert found that patients who develop established autoimmune disease with breast implants or more severe symptoms require not only capsulectomy but additional medical treatment as well for symptom improvement.
“BII is a complex, multisystem disease process that is first addressed with a capsulectomy but may require a more comprehensive look at the immune system, asking the question “why is the illness persistent despite surgery”. In my experience, many patients have underlying immune dysfunction that the implant triggers or exacerbates. The immune system may be dysfunctional from a variety of factors, such as Mast Cell Activation Syndrome (MCAS) and/or triggers, such as chronic infection, mold/mycotoxin illness, abnormal gut microbiome, hormone disruption, and stress, to name a few. The medical workup requires a look at these factors (and others) and how they interact with the immune system. I feel strongly about getting as much data as possible to confirm or rule out diagnoses being considered. Data allows the treatment to be more targeted and personalized for the patient. Every patient is different, and some patients will need mast cell targeted therapy to get better, but others might need detox and/or dietary changes and/or gut healing and/or antibiotics and/or herbs, and/or other treatment. Removing the triggers and starting the work on treating the underlying issues is the first step to getting better.”
— Dr. Tania Dempsey (New York)